×
About 205 results

ALLMedicine™ Pacemakers Center

Research & Reviews  71 results

MR guided radiation therapy of patients with cardiovascular implantable electronic devi...
https://doi.org/10.1016/j.prro.2021.08.011
Practical Radiation Oncology; Yang B, Yuan J et. al.

Sep 15th, 2021 - Magnetic resonance imaging guided radiation therapy (MRgRT) is reported for treating patients with an insertable cardiac monitor (ICM) and implantable cardiac pacemakers (ICP). All treatments were delivered using a 1.5 T MR-Linac. Among the four p...

Tissues attached to retrieved leadless pacemakers: Histopathological evaluation of tiss...
https://doi.org/10.1016/j.hrthm.2021.08.025
Heart Rhythm; Breeman KTN, du Long R et. al.

Aug 31st, 2021 - Leadless pacemakers (LPs) have proven safe and effective, but device revisions remain necessary. Either replacing the LP or implanting a new adjacent LP is feasible. Replacement seems more appealing, but encapsulation and tissue adhesions may hamp...

Leadless pacemakers: A review of current data and future directions.
https://doi.org/10.1016/j.pcad.2021.06.003
Progress in Cardiovascular Diseases; Middour TG, Chen JH et. al.

Aug 2nd, 2021 - Leadless pacemakers (LPs) have revolutionized the field of pacing by miniaturizing pacemakers and rendering them completelty intracardiac, hence reducing complications related to pacemaker pockets and transvenous leads. However, first generation L...

Use of Spinal Cord Stimulators in Patients With Pacemakers or Implantable Cardiac Defib...
https://doi.org/10.1111/ner.13514
Neuromodulation : Journal of the International Neuromodul... Martens JM, Fiala K et. al.

Jul 31st, 2021 - To assess the currently available evidence regarding associations between spinal cord stimulator (SCS) lead type, clinical indications for device placement, and interference between SCSs and cardiac pacemakers (CPMs)/implantable cardioverter-defib...

Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295005
American Journal of Cardiovascular Drugs : Drugs, Devices... Mascarenhas DAN, Mudumbi PC et. al.

Jul 23rd, 2021 - Antiarrhythmic drugs are often used in the management of patients with atrial fibrillation (AF). Sotalol is conventionally initiated in the inpatient setting for monitoring efficacy and adverse effects, including QTc interval prolongation and tors...

see more →

News  11 results

Evidence Builds for iPhone 12 Interference With Cardiac Devices
https://www.medscape.com/viewarticle/952780

Jun 9th, 2021 - Further evidence that powerful magnets in some Apple iPhones can interfere with cardiac implantable electronic devices (CIEDs) comes from a small study that also suggests some devices are more susceptible than others. The iPhone 12 Pro Max with Ma...

Traditional Pacemaker Complications Down With Leadless Device
https://www.medpagetoday.com/cardiology/arrhythmias/73736

Jun 27th, 2018 - Patients who got the Nanostim leadless pacemaker instead of a transvenous one had fewer complications through up to 18 months of follow-up, researchers said. Those receiving the leadless cardiac pacemaker (LCP) generally had fewer complications th...

CMS to Cover Leadless Pacemakers ... But Only in Studies
https://www.medpagetoday.com/cardiology/arrhythmias/61440

Nov 14th, 2016 - The Centers for Medicare & Medicaid Services aims to cover leadless pacemakers, but only in the context of use in FDA-approved studies, according to a draft of the agency's national coverage determination for the devices. The document details the ...

Women Receive Far Fewer CIEDs Than Men but Have Higher Survival Rates After Implant
https://www.medscape.com/viewarticle/847145

Jun 29th, 2015 - MILAN, ITALY — Women are being short-changed when it comes to receiving cardiac implantable electronic devices (CIEDs), which is especially concerning because they actually have higher survival rates than men after implantation of certain device t...

FDA expands uses for cardiac resynchronization devices
https://www.mdedge.com/internalmedicine/article/81600/arrhythmias-ep/fda-expands-uses-cardiac-resynchronization-devices
Elizabeth Mechcatie

Apr 11th, 2014 - The approval of cardiac resynchronization pacemakers and defibrillators manufactured by Medtronic has been expanded to include patients with atrioventricular block and less severe heart failure, the Food and Drug Administration announced on April.

see more →